Skip to main content
Premium Trial:

Request an Annual Quote

SRI to Lead Five-Member California Collaboration for Drug Development

NEW YORK, Aug. 1 - SRI International announced today that it will lead a drug development collaboration called PharmaSTART that will assist four California-based institutions in creating drug discovery plans.

 

The collaboration will include StanfordUniversity, Universityof California San Diego, Universityof California San Francisco, and the UCSF campus of the California Institute for Quantitative Biomedical Research.

 

According to Glenn Rice, vice president of SRI's Biosciences Division, there is a "major gap" in the translation of genomics and proteomics initiatives into new drugs. SRI hopes to bridge that gap by committing $500,000 and 1,000 hours of consulting time to PharmaSTART, which Rice said in a statement would "catalyze the emergence of new collaborations, new drug development initiatives, and new funding sources" among the participants. In particular, SRI will train principal investigators in the procedures necessary to win NIH and other government-funded grants.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.